TNF Pharmaceuticals, Inc.
TNFA
$0.22
$0.02814.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -483.98% | -339.60% | -34.82% | 2.37% | 73.68% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 256.18% | 261.63% | 1,938.61% | -225.69% | -1,503.27% |
| Change in Net Operating Assets | -212.41% | 1,280.13% | 445.21% | 391.68% | -63.42% |
| Cash from Operations | 30.85% | 23.70% | 32.03% | 21.29% | -5.79% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -430.56% | 9.42% | 85.86% | 288.19% | -73.30% |
| Cash from Investing | -430.56% | 9.42% | 85.86% | 288.19% | -73.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -4.67% | -4.67% | -4.67% | -100.00% | -- |
| Repurchase of Preferred Stock | 17.97% | -- | -- | -- | -- |
| Total Dividends Paid | -71.51% | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -3.80% | -16.19% | -45.12% | -114.30% | 135.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -229.81% | 7,873.91% | 143.29% | 103.71% | 899.48% |